Ixazomib Citrate

Ixazomib Citrate

Cat. No.: PI1239908203

Description: Ixazomib citrate is used for treating multiple myeloma in its finished dose formulation. Its mechanism of action involves functioning as a proteasome inhibitor, disrupting the normal function of proteasomes in cells.

Ixazomib Citrate
Product Details
CAS 1239908-20-3
Trade Names Ninlaro
Synonyms 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
Molecular Formula C20H23BCl2N2O9
Molecular Weight 517.1
Available Formulations Oral Solid
Technology Synthetic

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2